SERIAL GADOLINIUM-ENHANCED MRI IN UNTREATED PATIENTS WITH ACUTE OPTICNEURITIS - IMPLICATIONS FOR NATURAL-HISTORY

Citation
Jl. Frederiksen et al., SERIAL GADOLINIUM-ENHANCED MRI IN UNTREATED PATIENTS WITH ACUTE OPTICNEURITIS - IMPLICATIONS FOR NATURAL-HISTORY, Acta neurologica Scandinavica, 96(1), 1997, pp. 22-27
Citations number
27
Categorie Soggetti
Clinical Neurology
ISSN journal
00016314
Volume
96
Issue
1
Year of publication
1997
Pages
22 - 27
Database
ISI
SICI code
0001-6314(1997)96:1<22:SGMIUP>2.0.ZU;2-Q
Abstract
Serial brain MRIs with and without Gadolinium (Gd)-DTPA were performed in acute optic neuritis (ON). Material and methods - Fifty-nine untre ated patients (44 female) aged 20-57 years with ON underwent MRT media n 16 d from onset of symptoms of ON and at 1 and 12 months follow-up. Results - At onset of monosymptomatic ON (AMON), 13 of 40 (33%) patien ts had lesions on MRI without Gd-DTPA compared with 15 of 19 (79%) pat ients with ON as part of clinically definite multiple sclerosis (CDMS) . An initially abnormal MRI never normalized, whereas 3 patients with AMON with initially normal MRI had lesions at follow-up. In AMON enhan cing lesions were seen in 5% of patients at onset, in 12% after 1 mont h, and in 11% after 12 months. The corresponding figures in CDMS were 21%, 38%, and 33%. All enhancing lesions were also seen on MRI without Gd-DTPA. The number of lesions on MRI without Gd-DTPA increased signi ficantly with time in the 8 patients with AMON with enhancing lesions at one or more MRIs. New enhancing lesions appeared in 11 patients (6 AMON), of whom 3 (2 AMON) had an exacerbation. In contrast, 12 (5 AMON ) patients had an exacerbation, being accompanied by new enhancing les ions in only 3 (2 AMON) patients. Conclusion - Gd-DTPA did not increas e the sensitivity of MRI, which was significantly higher in CDMS than in AMON, but improved the understanding of the natural history of AMON and CDMS. The dynamics of enhancing lesions did not correlate well wi th exacerbations. Serial MRI and clinical assessment are supplementary in monitoring disease activity.